CDC Recommends mRNA Vaccines Over Johnson & Johnson

Posted by Argentum on December 17, 2021

The CDC yesterday announced that it is preferable to get an mRNA vaccine—such as Pfizer or Moderna in a two-shot series—over the Johnson & Johnson one-shot vaccine.  

Read More

Topics: Vaccine

Boosters Recommended for Ages 16-17; Preventive Use of Monoclonal Antibodies Gets EUA

Posted by Argentum on December 9, 2021

CDC director Dr. Rochelle Walensky today announced that the CDC recommends and encourages booster shots for ages 16 and 17, as well as reinforcing the previous announcement that those older than 18 get the booster.  

Read More

Topics: Vaccine

CDC Says 18+ ‘Should’ Get Booster

Posted by Argentum on December 1, 2021

The CDC made a change to its recommendations, saying “Everyone ages 18 and older should get a booster shot.” Previously, the CDC had said everyone “may” get a booster. This stronger recommendation comes in the wake of the emergence of the Omicron variant and the prospect of winter holidays, travel, and close quarters.  

Read More

Topics: Vaccine

Omicron Variant: Resources to Keep Up with the Changing Picture

Posted by Argentum on November 29, 2021

While the World Health Organization has classified a new variant of the coronavirus, Omicron, as a “variant of concern,” as of Nov. 26, no cases have been reported in the United States.

Read More

Topics: Vaccine

Boosters for All Move Goes to CDC Committee

Posted by Argentum on November 19, 2021

The U.S. Food and Drug Administration has authorized a single booster dose for all individuals 18 and older who have had their primary vaccinations. The booster would be given six months after the primary series with Moderna or Pfizer, and two months after Johnson & Johnson.

Read More

Topics: Vaccine

CDC OKs Fourth Shot for Immunocompromised

Posted by Argentum on October 27, 2021

The CDC has updated guidance for people who are moderately to severely immunocompromised: 

Read More

Topics: Vaccine

FDA Committee Recommends Allowing Vaccine for Ages 5-11

Posted by Argentum on October 27, 2021

A U.S. Food and Drug Administration advisory committee has recommended authorization of Pfizer-BioNTech pediatric vaccine for ages 5 to 11.  

Read More

Topics: Vaccine

CDC Expands Booster Eligibility, OKs Mix and Match

Posted by Argentum on October 22, 2021

The CDC has expanded booster eligibility and its recommendations to include “mix and match” dosing—receiving a booster of a different type from the primary vaccine.  

Read More

Topics: Vaccine

FDA Authorizes ‘Mix and Match’ Boosters

Posted by Argentum on October 21, 2021

The U.S. Food and Drug Administration yesterday amended its emergency use authorizations for several actions regarding booster doses of COVID-19 vaccines, including allowing the use of heterologous, or “mix and match” booster doses: using a different type of vaccine from the primary dose for a booster dose.

Read More

Topics: Vaccine

Johnson & Johnson Booster Recommended for All 18 and Older

Posted by Argentum on October 15, 2021

An FDA independent expert panel has recommended people 18 and older have a booster shot of the Johnson & Johnson vaccine, and that it be given at least two months after the first shot. The Johnson & Johnson vaccine was given as a single dose. 

Read More

Topics: Vaccine

Subscribe to Instant Email Updates

See More COVID-19 Announcements

Read more announcements related to COVID-19 on our Coronavirus Blog and access more information on:

SEE BLOG

Stay Updated on COVID-19

Find all of our latest updates on developments related to COVID-19 on our Coronavirus Toolkit.

SEE TOOLKIT